CBD News

The Portland attorney who previously settled 10 lawsuits against Curaleaf for its THC/CBD product mix-up is now seeking $200 per customer regardless of whether they were made ill by the products.

The majority of CBD products marketed for sleep are inaccurately labeled for CBD, CBN, or melatonin content, according to a recent study by Leafreport.

George Harrison’s 1970 album ‘All Things Must Pass’ will be honored in a new CBD/CBG product line from Dad Grass, with the promise of a “pleasant-but-manageable buzz.”

The U.S. Trademark Trial and Appeal Board declined to register a hemp CBD company’s trademark, citing the federal prohibition of CBD and saying the product meets the definition of a drug but has not been approved by the FDA.

A recent poll found that less than half of U.S. parents know much about the use of CBD products with regard to children and most have never tried CBD themselves.

The NFL is donating $1 million to researchers to study the effects of cannabinoids on pain management in elite athletes.

A new report found a 5,100% price difference between the most expensive and most affordable CBD consumer products.

Tennessee lawmakers are set to consider multiple pieces of cannabis reform legislation this year, including a bill to tax delta-8 THC and CBD products, as well as broader medical and adult-use cannabis bills.

The Constitutional Council of France ruled that CBD is not addictive or harmful, overturning a ban on the possession, use, and sale of CBD put in place in December.

Many advocates and patients cite cannabis as a powerful sleep aid, but what does the recent research say?

The biotech pharma firm ANANDA Scientific Inc. announced it has received FDA approval to study a CBD-based drug as a treatment for opioid-use disorder.

Curaleaf has settled 10 lawsuits related to its mix-up last year of THC and CBD tinctures at a Portland, Oregon facility. Additional cases, including a wrongful death suit, are still pending.

Minnesota cannabis officials said that hemp-derived tinctures and other CBD and Delta-8 THC products are illegal because the FDA has not formally approved the cannabinoid products.

Curaleaf is partnering with Southern Glazer’s Wine & Spirits, the world’s largest alcohol distributor, to distribute its Hemp and Select CBD products.

Lawmakers and other officials in Montana are contesting some of the state’s proposed adult-use cannabis regulations, including a provision to ban the sale of hemp-derived CBD products by cannabis retailers.

Under a provision in Montana’s adult-use cannabis rules, licensed cannabis companies are not allowed to grow, process, or sell hemp products, which effectively relegates the retail sales of hemp-derived CBD products to gas stations, corner markets, and grocery stores.

Actor Clint Eastwood won about $6.1 million in a lawsuit against a Lithuanian company that used Eastwood’s image and likeness to promote its CBD products without permission.

An Idaho man is suing Curaleaf over a product mixup that resulted in the company’s Select-brand CBD drops being recalled last week for containing THC.

The Oregon Liquor and Cannabis Commission last week recalled Cura’s Select brand tincture products after the company reportedly mixed up a line of THC and CBD products.

The U.S. Food and Drug Administration has denied two applications from companies seeking to sell CBD hemp extracts as a dietary supplement because CBD is an approved drug.

A White House committee is recommending changes to business categories that would re-classify cannabis retail stores alongside smoking shops, among other updates.

Lately, CBD brands have started adding adaptogens—plants and mushrooms with healing properties—into their products. Unfortunately, they rarely attribute these ancient medicines to their historical and cultural context.